February 21, 2026
Article News

‘High revenue, low trust’: Why Sharks rejected Ayuvya despite Rs 51 crore sales on Shark Tank India

  • January 29, 2026
  • 0

On Shark Tank India Season 5, Ayuvya walked into the Tank with numbers that might often cease the room, however walked out and not using a deal after

‘High revenue, low trust’: Why Sharks rejected Ayuvya despite Rs 51 crore sales on Shark Tank India


On Shark Tank India Season 5, Ayuvya walked into the Tank with numbers that might often cease the room, however walked out and not using a deal after the dialogue shifted from income to duty.

Based by Tanishk Pandey, Astha Jain, and Pawanjot Kaur, Ayuvya is an ayurvedic wellness model that pitched alongside its sister model, ImFresh. The founders sought Rs 1 crore for 0.5% fairness, valuing the 2 companies collectively at Rs 200 crore.

The pitch started strongly. The founders revealed that Ayuvya had generated Rs 51.5 crore in income in FY24–25, with projections of Rs 70 crore for the next yr. The numbers instantly caught the Sharks’ consideration and set excessive expectations.

Nonetheless, the dialog quickly moved past topline progress. Kunal Bahl questioned whether or not the expansion fee was slowing in comparison with earlier years and requested about buyer repeat behaviour—metrics the founders have been unable to obviously clarify. The shortage of readability raised early issues about long-term sustainability.

The dialogue then turned to advertising. Aman Gupta criticised the model’s social media commercials, calling them poor in high quality. When Tanishk defended the method by saying that “ugly advertisements” have been trending as a result of they felt extra genuine, the Sharks remained unconvinced.

The turning level got here when the panel realised that none of Ayuvya’s ayurvedic merchandise had undergone medical trials. Pawanjot argued that the formulations have been primarily based on historic texts and conventional practices, however the Sharks pushed again, stressing the significance of validation in health-related merchandise.

Kunal Bahl opted out, saying that whereas the founders had constructed a formidable enterprise, belief needed to come earlier than therapy. “Pehle vishwas banao,” he mentioned, a line that summed up the panel’s concern.

Ritesh Agarwal echoed the sentiment, whereas Aman Gupta identified that regardless of the valuation, Ayuvya had not but change into a model shoppers may actually depend on.

Ultimately, Ayuvya exited the Tank with out an funding.